Skip to main content
Top
Published in: Respiratory Research 1/2010

Open Access 01-12-2010 | Research

Characterisation of COPD heterogeneity in the ECLIPSE cohort

Authors: Alvar Agusti, Peter MA Calverley, Bartolome Celli, Harvey O Coxson, Lisa D Edwards, David A Lomas, William MacNee, Bruce E Miller, Steve Rennard, Edwin K Silverman, Ruth Tal-Singer, Emiel Wouters, Julie C Yates, Jørgen Vestbo, the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators

Published in: Respiratory Research | Issue 1/2010

Login to get access

Abstract

Background

Chronic obstructive pulmonary disease (COPD) is a complex condition with pulmonary and extra-pulmonary manifestations. This study describes the heterogeneity of COPD in a large and well characterised and controlled COPD cohort (ECLIPSE).

Methods

We studied 2164 clinically stable COPD patients, 337 smokers with normal lung function and 245 never smokers. In these individuals, we measured clinical parameters, nutritional status, spirometry, exercise tolerance, and amount of emphysema by computed tomography.

Results

COPD patients were slightly older than controls and had more pack years of smoking than smokers with normal lung function. Co-morbidities were more prevalent in COPD patients than in controls, and occurred to the same extent irrespective of the GOLD stage. The severity of airflow limitation in COPD patients was poorly related to the degree of breathlessness, health status, presence of co-morbidity, exercise capacity and number of exacerbations reported in the year before the study. The distribution of these variables within each GOLD stage was wide. Even in subjects with severe airflow obstruction, a substantial proportion did not report symptoms, exacerbations or exercise limitation. The amount of emphysema increased with GOLD severity. The prevalence of bronchiectasis was low (4%) but also increased with GOLD stage. Some gender differences were also identified.

Conclusions

The clinical manifestations of COPD are highly variable and the degree of airflow limitation does not capture the heterogeneity of the disease.
Literature
3.
go back to reference Agusti AG: COPD, a multicomponent disease: implications for management. Respir Med 2005, 99:670–682.CrossRefPubMed Agusti AG: COPD, a multicomponent disease: implications for management. Respir Med 2005, 99:670–682.CrossRefPubMed
4.
go back to reference Vestbo J, Anderson W, Coxson HO, Crim C, Dawber F, Edwards L, Hagan G, Knobil K, Lomas DA, MacNee W, et al.: Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). Eur Respir J 2008, 31:869–873.CrossRefPubMed Vestbo J, Anderson W, Coxson HO, Crim C, Dawber F, Edwards L, Hagan G, Knobil K, Lomas DA, MacNee W, et al.: Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). Eur Respir J 2008, 31:869–873.CrossRefPubMed
5.
go back to reference Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ: The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease. N Engl J Med 2004, 350:1005–1012.CrossRefPubMed Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ: The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease. N Engl J Med 2004, 350:1005–1012.CrossRefPubMed
6.
go back to reference Han MK, Postma D, Mannino DM, Giardino ND, Buist S, Curtis JL, Martinez FJ: Gender and Chronic Obstructive Pulmonary Disease: Why It Matters. Am J Respir Crit Care Med 2007, 176:1179–1184.CrossRefPubMedPubMedCentral Han MK, Postma D, Mannino DM, Giardino ND, Buist S, Curtis JL, Martinez FJ: Gender and Chronic Obstructive Pulmonary Disease: Why It Matters. Am J Respir Crit Care Med 2007, 176:1179–1184.CrossRefPubMedPubMedCentral
7.
go back to reference Meguro M, Barley EA, Spencer S, Jones PW: Development and Validation of an Improved, COPD-Specific Version of the St. George Respiratory Questionnaire. Chest 2007, 132:456–463.CrossRefPubMed Meguro M, Barley EA, Spencer S, Jones PW: Development and Validation of an Improved, COPD-Specific Version of the St. George Respiratory Questionnaire. Chest 2007, 132:456–463.CrossRefPubMed
8.
go back to reference American Thoracic Society Official Statement. Standardization of Spirometry. 1994 Update Am J Respir Crit Care Med 1995, 152:1107–1136. American Thoracic Society Official Statement. Standardization of Spirometry. 1994 Update Am J Respir Crit Care Med 1995, 152:1107–1136.
9.
go back to reference ATS Statement: Guidelines for the Six-Minute Walk Test Am J Respir Crit Care Med 2002, 166:111–117. ATS Statement: Guidelines for the Six-Minute Walk Test Am J Respir Crit Care Med 2002, 166:111–117.
10.
go back to reference Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC: Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993, 16:5–40.CrossRefPubMed Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC: Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993, 16:5–40.CrossRefPubMed
11.
go back to reference Patel BD, Coxson HO, Pillai SG, Agusti AG, Calverley PM, Donner CF, Make BJ, Muller NL, Rennard SI, Vestbo J, et al.: Airway Wall Thickening and Emphysema Show Independent Familial Aggregation in COPD. Am J Respir Crit Care Med 2008, 178:500–505.CrossRefPubMed Patel BD, Coxson HO, Pillai SG, Agusti AG, Calverley PM, Donner CF, Make BJ, Muller NL, Rennard SI, Vestbo J, et al.: Airway Wall Thickening and Emphysema Show Independent Familial Aggregation in COPD. Am J Respir Crit Care Med 2008, 178:500–505.CrossRefPubMed
13.
go back to reference Selman M, Carrillo G, Estrada A, Mejia M, Becerril C, Cisneros J, Gaxiola M, Perez-Padilla R, Navarro C, Richards T, et al.: Accelerated variant of idiopathic pulmonary fibrosis: clinical behavior and gene expression pattern. PLoS ONE 2007, 2:e482.CrossRefPubMedPubMedCentral Selman M, Carrillo G, Estrada A, Mejia M, Becerril C, Cisneros J, Gaxiola M, Perez-Padilla R, Navarro C, Richards T, et al.: Accelerated variant of idiopathic pulmonary fibrosis: clinical behavior and gene expression pattern. PLoS ONE 2007, 2:e482.CrossRefPubMedPubMedCentral
14.
go back to reference Mannino DM, Reichert MM, Davis KJ: Lung function decline and outcomes in an adult population. Am J Respir Crit Care Med 2006, 173:985–990.CrossRefPubMed Mannino DM, Reichert MM, Davis KJ: Lung function decline and outcomes in an adult population. Am J Respir Crit Care Med 2006, 173:985–990.CrossRefPubMed
15.
go back to reference He JQ, Foreman MG, Shumansky K, Zhang X, Akhabir L, Sin DD, Man SF, DeMeo DL, Litonjua AA, Silverman EK, et al.: Associations of IL6 polymorphisms with lung function decline and COPD. Thorax 2009, 64:698–704.CrossRefPubMedPubMedCentral He JQ, Foreman MG, Shumansky K, Zhang X, Akhabir L, Sin DD, Man SF, DeMeo DL, Litonjua AA, Silverman EK, et al.: Associations of IL6 polymorphisms with lung function decline and COPD. Thorax 2009, 64:698–704.CrossRefPubMedPubMedCentral
16.
go back to reference Kohansal R, Martinez-Camblor P, Agusti A, Buist AS, Mannino DM, Soriano JB: The Natural History of Chronic Airflow Obstruction Revisited: An Analysis of the Framingham Offspring Cohort. Am J Respir Crit Care Med 2009, 180:3–10.CrossRefPubMed Kohansal R, Martinez-Camblor P, Agusti A, Buist AS, Mannino DM, Soriano JB: The Natural History of Chronic Airflow Obstruction Revisited: An Analysis of the Framingham Offspring Cohort. Am J Respir Crit Care Med 2009, 180:3–10.CrossRefPubMed
17.
go back to reference Jones PW: Issues concerning health-related quality of life in COPD. Chest 1995,107(Suppl):187S-193S.CrossRefPubMed Jones PW: Issues concerning health-related quality of life in COPD. Chest 1995,107(Suppl):187S-193S.CrossRefPubMed
19.
go back to reference O'Reilly J, Jones MM, Parnham J, Lovibond K, Rudolf M: Management of stable chronic obstructive pulmonary disease in primary and secondary care: summary of updated NICE guidance. Brit Med J 2010, 340:c3134.CrossRefPubMed O'Reilly J, Jones MM, Parnham J, Lovibond K, Rudolf M: Management of stable chronic obstructive pulmonary disease in primary and secondary care: summary of updated NICE guidance. Brit Med J 2010, 340:c3134.CrossRefPubMed
20.
go back to reference Burgel PR, Nesme-Meyer P, Chanez P, Caillaud D, Carre P, Perez T, Roche N: Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects. Chest 2009, 135:975–982.CrossRefPubMed Burgel PR, Nesme-Meyer P, Chanez P, Caillaud D, Carre P, Perez T, Roche N: Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects. Chest 2009, 135:975–982.CrossRefPubMed
21.
go back to reference Schols AM, Broekhuizen R, Weling-Scheepers CA, Wouters EF: Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005, 82:53–59.PubMed Schols AM, Broekhuizen R, Weling-Scheepers CA, Wouters EF: Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005, 82:53–59.PubMed
22.
go back to reference Barnes PJ, Celli BR: Systemic manifestations and comorbidities of COPD. Eur Respir J 2009, 33:1165–1185.CrossRefPubMed Barnes PJ, Celli BR: Systemic manifestations and comorbidities of COPD. Eur Respir J 2009, 33:1165–1185.CrossRefPubMed
23.
go back to reference Patel IS, Vlahos I, Wilkinson TM, Lloyd-Owen SJ, Donaldson GC, Wilks M, Reznek RH, Wedzicha JA: Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004, 170:400–407.CrossRefPubMed Patel IS, Vlahos I, Wilkinson TM, Lloyd-Owen SJ, Donaldson GC, Wilks M, Reznek RH, Wedzicha JA: Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004, 170:400–407.CrossRefPubMed
24.
go back to reference Prescott E, Bjerg AM, Andersen PK, Lange P, Vestbo J: Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur Respir J 1997, 10:822–827.PubMed Prescott E, Bjerg AM, Andersen PK, Lange P, Vestbo J: Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur Respir J 1997, 10:822–827.PubMed
25.
go back to reference de Torres JP, Casanova C, Hernandez C, Abreu J, Aguirre-Jaime A, Celli BR: Gender and COPD in patients attending a pulmonary clinic. Chest 2005, 128:2012–2016.CrossRefPubMed de Torres JP, Casanova C, Hernandez C, Abreu J, Aguirre-Jaime A, Celli BR: Gender and COPD in patients attending a pulmonary clinic. Chest 2005, 128:2012–2016.CrossRefPubMed
26.
go back to reference Burgel PR, Paillasseur JL, Caillaud D, Tillie-Leblond I, Chanez P, Escamilla R, Court-Fortune I, Perez T, Carré P, Roche N: Clinical COPD phenotypes: a novel approach using principal component and cluster analyses. Eur Respir J 2010, in press. Burgel PR, Paillasseur JL, Caillaud D, Tillie-Leblond I, Chanez P, Escamilla R, Court-Fortune I, Perez T, Carré P, Roche N: Clinical COPD phenotypes: a novel approach using principal component and cluster analyses. Eur Respir J 2010, in press.
27.
go back to reference Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL, Fabbri LM, Goldin JG, Jones PW, MacNee W, et al.: COPD Phenotypes: The Future of COPD. Am J Respir Crit Care Med 2010,182(5):598–604.CrossRefPubMed Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL, Fabbri LM, Goldin JG, Jones PW, MacNee W, et al.: COPD Phenotypes: The Future of COPD. Am J Respir Crit Care Med 2010,182(5):598–604.CrossRefPubMed
Metadata
Title
Characterisation of COPD heterogeneity in the ECLIPSE cohort
Authors
Alvar Agusti
Peter MA Calverley
Bartolome Celli
Harvey O Coxson
Lisa D Edwards
David A Lomas
William MacNee
Bruce E Miller
Steve Rennard
Edwin K Silverman
Ruth Tal-Singer
Emiel Wouters
Julie C Yates
Jørgen Vestbo
the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2010
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-11-122

Other articles of this Issue 1/2010

Respiratory Research 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine